Fundraising FoxMedTech Venture Partners — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells.
BiotechHealthtechMedical Devices
David G. Brachman, MD, FASTRO(Co-Founder and Chief Technology Officer)Heyoung McBride, MD, MS, FASTRO(Co-Founder)Peter Nakaji, MD(Co-Founder)inEmad Youssef, MD(Co-Founder)Theresa Thomas, MS, CCRC(Co-Founder)Per Langoe(Chief Executive Officer)in
Co-investorsAccelmed PartnersBlueStone Venture PartnersEvidity Health CapitalFemHealth VenturesGilde HealthcareMVM Life Science Partners+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.